PMID: 42572119

Predicted 10-Year Cardiovascular Disease Risk Reduction with Tirzepatide Use Over Three Years for Primary Prevention of Cardiovascular Disease in Obesity.

Sattar Naveed, Mamas Mamas, Li Runjia, García-Pérez Luis-Emilio, Chen Kevin L, Upadhyay Navneet, Glass Leonard, Batterham Rachel L, Dimitriadis Georgios K, Liu-Seifert Hong

European journal of preventive cardiology · 2026

This entry links to third-party literature. For research use only.